Effect of Pistacia atlantica kurdica gum on diabetic gastroparesis symptoms
A randomized, triple-blind placebo-controlled clinical trial
Keywords:
Gastroparesis, Diabetes mellitus, Pistacia atlantica, Persian medicineAbstract
Background: Gastroparesis is a recognized problem of type 1 and 2 diabetes mellitus that is defined by delayed gastric emptying. Due to insufficient satisfaction of current treatments, the use of complementary and alternative medicine in this field seems essential. According to Persian medicine, Pistacia atlantica gum has proper effect on gastrointestinal disorder specially stomach diseases. Objective: The aim of this study was to assess the effect of Pistacia atlantica gum on diabetic gastroparesis symptoms. Methods: A triple-blind randomized placebo-controlled trial on subjects with diabetic gastroparesis was conducted at the clinic of Imam Reza Hospital in Mashhad city in Iran, from November 2016 to May 2017. Fifty-four patients (16.7% males and 83.3% females) enrolled in the 8-week study and were randomly divided into two groups of intervention Pistacia atlantica and placebo groups. Both of the groups had received current dietary advice. Severity of gastroparesis symptoms was assessed with a Gastroparesis cardinal symptom index (GCSI) questionnaire. SPSS software version 16 was used to analyze the data and Generalized Estimating Equation (GEE) model, Independent-samples t-test, Paired-samples t-test, Mann-Whitney U test, and Wilcoxon signed-rank test were used to assess variables. Results: All gastroparesis symptoms of patients (14.6% diabetes type 1 and 85.4% diabetes type 2) including nausea /vomiting, postprandial fullness/early satiety, and bloating were significantly declined in each group during study (p˂0.0001). Pistacia atlantica gum significantly reduced severity of gastroparesis symptoms including Postprandial fullness/early satiety (p=0.04), Bloating (p˂0.0001), and GCSI scores (p=0.001) versus placebo. Systolic blood pressure (p=0.006), BMI (p=0.018), and HbA1c (p=0.038) significantly decreased in the Pistacia atlantica group after the intervention. Conclusion: This study showed that daily consumption of Pistacia atlantica gum for one month improves diabetic gastroparesis symptoms. Trial registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the code of IRCT2016110630739N1. Funding: This study was supported by funding (grant no.: 950153) from the Mashhad University of Medical Sciences Research Council, Mashhad, Iran.References
Kasper DL, Fauci AS, Hauser S, Longo D, Jameson JL, Loscalzo J. Harrison's Principles of Internal
Medicine 19/E (Vol 4): McGraw-Hill Education; 2015.
Soykan I, Sivri B, Sarosiek I, Kiernan B, Mccallum RW. Demography, clinical characteristics,
psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig
Dis Sci. 1998; 43(11): 2398-404. doi: 10.1023/A:1026665728213.
Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic
gastroparesis. Clin Gastroenterol Hepatol. 2011; 9(1): 5-12. doi: 10.1016/j.cgh.2010.09.022.
Shin AS, Camilleri M. Diagnostic assessment of diabetic gastroparesis. Diabetes. 2013; 62(8): 2667-73.
doi: 10.2337/db12-1706.
Maleki D, Locke GR, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, et al. Gastrointestinal tract
symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000; 160(18): 2808- 16. doi: 10.1001/archinte.160.18.2808.
Bharucha AE, Batey-Schaefer B, Cleary PA, Murray JA, Cowie C, Lorenzi G, et al. Delayed gastric
emptying is associated with early and long-term hyperglycemia in type 1 diabetes mellitus.
Gastroenterology. 2015; 149(2): 330-9. doi: 10.1053/j.gastro.2015.05.007.
Lee A, Kuo B. Metoclopramide in the treatment of diabetic gastroparesis. Expert Rev Endocrinol Metab.
; 5(5): 653-62. doi: 10.1586/eem.10.41. PMID: 21278804, PMCID: PMC3027056.
McCarty TR, Rustagi T. Endoscopic treatment of gastroparesis. World J Gastroenterol. 2015; 21(22): 6842- 9. doi: 10.3748/wjg.v21.i22.6842. PMID: 26078560, PMCID: PMC4462724.
Janssens J, Peeters T, Vantrappen G, Tack J, Urbain J, De Roo M, et al. Improvement of gastric emptying
in diabetic gastroparesis by erythromycin: preliminary studies. N Engl J Med. 1990; 322(15): 1028-31. doi:
1056/NEJM199004123221502. PMID: 2320062.
Casey DE. Metoclopramide side effects. Ann Intern Med. 1983; 98(5_Part_1): 673-4. doi: 10.7326/0003- 4819-98-5-673_3.
Grimes J, Hassan M, Preston D. Adverse neurologic effects of metoclopramide. Can Med Assoc J. 1982;
(1): 23-5. PMID: 7059869, PMCID: PMC1862808.
Bateman D, Rawlins M, Simpson JM. Extrapyramidal reactions with metoclopramide. BMJ. 1985;
(6500): 930-2. doi: 10.1136/bmj.291.6500.930
Ponti D, Nucci D. Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment
Pharmacol Ther. 1999; 13(12): 1585-91. PMID: 10594392.
McCallum R, Cynshi O. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in
patients with gastroparesis–a randomized, multicentre, placebo‐controlled study. Aliment Pharmacol
Ther. 2007; 26(8): 1121-30. doi: 10.1111/j.1365-2036.2007.03461.x.
Pang B, Zhou Q, Li JL, Zhao LH, Tong XL. Treatment of refractory diabetic gastroparesis: Western
medicine and traditional Chinese medicine therapies. World J Gastroenterol. 2014; 20(21): 6504-14. doi:
3748/wjg.v20.i21.6504. PMID: 24914371, PMCID: PMC4047335.
Avicenna. Al-Qanun fi al-Tibb (The Canon of Medicine). Beirut: Alamy Le- Al-Matbooat institute; 2012.
Borhani M, Khoshzaban Z, Jodeiri B, Naseri M, Kamlinejad M, Faghihzade S. Comparison between used
herbs for treatment of gastroesophageal reflux disease [GERD] in Iranian Traditional of Medicine. Adv
Environ Biol. 2014: 773-82.
Aghili MH. Makhzan al Advie. Tehran: Tehran University of Medical Sciences; 2009.
AzamKhan M. Eksir Azam. The Institute for Medical History Islamic and Complementary Medicine.
Tehran : Tehran University of Medical Sciences; 2004.
Bozorgi M, Memariani Z, Mobli M, Salehi Surmaghi MH, Shams-Ardekani MR, Rahimi R. Five Pistacia
species (P. vera, P. atlantica, P. terebinthus, P. khinjuk, and P. lentiscus): a review of their traditional uses,
phytochemistry, and pharmacology. Sci World J. 2013; 2013. doi: 10.1155/2013/219815.
Ghalem B, Benali M. Bactericidal activity of Pistacia atlantica. Desf mastic gum against certain pathogens.
Afr J Plant Sci. 2009; 3(1): 013-5.
Minaiyan M, Karimi F, Ghannadi A. Anti-inflammatory effect of Pistacia atlantica subsp. kurdica volatile
oil and gum on acetic acid-induced acute colitis in rat. RJP. 2015; 2(2): 1-12.
Ghalem B, Mohamed B. Essential oil from gum of Pistacia atlantica Desf: screening of antimicrobial
activity. Afr J Pharm Pharmacol. 2009; 3(3): 87-91.
Sharifi MS, Hazell SL. Isolation, analysis and antimicrobial activity of the acidic fractions of Mastic,
Kurdica, Mutica and Cabolica gums from genus Pistacia. Glob J Health Sci. 2012; 4(1): 217. doi:
5539/gjhs.v4n1p217.
Barrero A, Herrador M, Arteaga J, Akssira M, Mellouki F, Belgarrabe A, et al. Chemical composition of
the essential oils of Pistacia atlantica Desf. J Essent Oil Res. 2005; 17(1): 52-4. doi:
1080/10412905.2005.9698828.
Parkman H, Carlson M, Gonyer D. Metoclopramide nasal spray is effective in symptoms of gastroparesis
in diabetics compared to conventional oral tablet. J Neurogastroenterol Motil. 2014; 26(4): 521-8. doi:
1111/nmo.12296.
Revicki D, Rentz A, Dubois D, Kahrilas P, Stanghellini V, Talley N, et al. Development and validation of a
patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.
Aliment Pharmacol Ther. 2003; 18(1): 141-50. doi: 10.1046/j.1365-2036.2003.01612.x.
Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, et al. Gastroparesis Cardinal
Symptom Index (GCSI): development and validation of a patient reported assessment of severity of
gastroparesis symptoms. Qual Life Res. 2004; 13(4): 833-44. doi: 10.1023/B:QURE.0000021689.86296.e4.
Revicki D, Camilleri M, Kuo B, Norton N, Murray L, Palsgrove A, et al. Development and content validity
of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther. 2009; 30(6): 670-80. doi:
1111/j.1365-2036.2009.04078.x.
Revicki D, Camilleri M, Kuo B, Szarka L, McCormack J, Parkman H. Evaluating symptom outcomes in
gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index‐
Daily Diary (GCSI ‐ DD). J Neurogastroenterol Motil. 2012; 24(5): 456-63. doi: 10.1111/j.1365- 2982.2012.01879.x.
Groop L, Defronzo R, Luzi L, Melander A. Hyperglycaemia and absorption of sulphonylurea drugs.
Lancet. 1989; 334(8655): 129-30. doi: 10.1016/S0140-6736(89)90184-0.
Delazar A, Reid R, Sarker S. GC-MS analysis of the essential oil from the oleoresin of Pistacia atlantica
var. mutica. Chem Nat Compd. 2004; 40(1): 24-7. doi: 10.1023/B:CONC.0000025459.72590.9e.
Olausson EA, Störsrud S, Grundin H, Isaksson M, Attvall S, Simrén M. A small particle size diet reduces
upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J
Gastroenterol. 2014; 109(3): 375-85. doi: 10.1038/ajg.2013.453. PMID: 24419482.
Kartalis A, Didagelos M, Georgiadis I, Benetos G, Smyrnioudis N, Marmaras H, et al. Effects of Chios
mastic gum on cholesterol and glucose levels of healthy volunteers: A prospective, randomized, placebo-controlled, pilot study (CHIOS-MASTIHA). Eur J Prev Cardiol. 2016; 23(7): 722-9. doi:
1177/2047487315603186.
Choi KM, Gibbons SJ, Nguyen TV, Stoltz GJ, Lurken MS, Ordog T, et al. Heme oxygenase-1 protects
interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology. 2008;
(6): 2055-64. doi: 10.1053/j.gastro.2008.09.003. PMID: 18926825 PMCID: PMC2796242.
Sun J. D-Limonene: safety and clinical applications. Altern Med Rev. 2007; 12(3): 259. PMID: 18072821.
Singh B, Sharma RA. Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical
applications. 3 Biotech. 2015; 5(2): 129-51. doi: 10.1007/s13205-014-0220-2.
Soni S. Effect of Cinnamomum Zeylenicum Nees Bark Oil on Drug Induced Diabetic Gastroparesis in
Rats. AJBPS. 2012; 2(9).
Benhammou N, Bekkara FA, Panovska TK. Antioxidant and antimicrobial activities of the Pistacia
lentiscus and Pistacia atlantica extracts. Afr J Pharm Pharmacol. 2008; 2(2): 22-8.
Saeb M, Nazifi S, Yavari M. Studies on the effects of turpentine oil on the serum concentration of lipids
and lipoproteins of male rabbits. IJEM. 2005; 7(1): 73-8.
Kasabri V, Afifi FU, Hamdan I. In vitro and in vivo acute antihyperglycemic effects of five selected
indigenous plants from Jordan used in traditional medicine. J Ethnopharmacol. 2011; 133(2): 888-96. doi:
1016/j.jep.2010.11.025. PMID: 21093568.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
